DOCetaxel with or without radiation Therapy for resectable Oesophageal adenocarcinoma based on early PET Response to induction chemotherapy (DOCTOR). [ 2011 - 2016 ]

Research Grant

Researchers: Prof Andrew Barbour (Principal investigator) ,  A/Pr Euan Walpole ,  Dr Garrett Smith ,  Prof Bernard Smithers ,  Prof Bryan Burmeister
View all 7 related researchers

Brief description Oesophageal cancer continues to have poor survival despite surgery. Patients responding to pre-operative chemotherapy have better survival than those who do not. This study proposes using early FDG-PET scan to identify patients not responding to standard chemotherapy. This will permit the timely change of therapy to alternative regimens with a newer agent with or without radiotherapy, aiming to improve outcomes. This represents a paradigm shift in the management of oesophageal cancer.

Funding Amount $AUD 1,024,738.51

Funding Scheme Project Grants

Notes Standard Project Grant